Results 201 to 210 of about 5,331,742 (248)

Identification of CTHRC1 as a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma by Bioinformatics Analysis. [PDF]

Transl Oncol
Li S, Kang Y, Qi Y.
europepmc   +1 more source

Exploring the Anticancer Potential of Schiff Base Complexes: A Mini‐Review

ChemMedChem, Volume 21, Issue 17, 14 September 2026.
Schiff base metal complexes as promising anticancer agents: highlighting DNA interactions, cytotoxicity, molecular targets, and mechanisms of cancer cell death. Schiff bases are well known for their ability to form stable coordination compounds with several transition metals, making them valuable for medicinal chemistry purposes.
Atif Ahmad, Anam, Marcos V. Palmeira‐Mello, Sabir Khan, José Clayston Melo Pereira   +4 more
wiley   +1 more source

Advances and challenges in immunotherapy for advanced esophageal squamous cell carcinoma. [PDF]

Front Immunol
Wang Y, Li H, Zhao P, Li Z, Zhang S.
europepmc   +1 more source

How bone mis‐segmentation affects MRI‐based sCT dosimetry in head and neck radiotherapy: A CT‐referenced study

Journal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Magnetic resonance imaging (MRI) is commonly used for head‐and‐neck (H&N) delineation in radiotherapy (RT) owing to the lack of contrast in computed tomography (CT) images. MRI‐based dosimetry is not yet fully developed for the H&N area due to the inter‐patient variability and the difficulty of accurately quantifying cortical bone ...
Laura Sayaque, Nils Tanneau, Charlène Bouyer, Benjamin Leporq, Oliver Hamelin, Frank Pilleul, Vincent Gregoire, Olivier Beuf   +7 more
wiley   +1 more source

2-Hydroxyisobutyrylation and Phosphorylation Crosstalk Guides Metastasis Prediction and Immunotherapy in Esophageal Squamous Cell Carcinoma. [PDF]

MedComm (2020)
Li J, Li S, Yu X, Mu Q, Luo M, Wang Y, Liu Z, Gu C, Chen J, He W, Yang T, He Y, Pei X, Lin M, Li Z, Liu J, Zhao B, Zhang F, Liu J, Li B, Xu W.   +20 more
europepmc   +1 more source

Clinical evaluation of novel deep learning‐based auto‐segmentation software: Utility and potential pitfalls

Journal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Accurate contouring of target volumes and organs at risk is critical in radiotherapy. While deep learning (DL) models offer automated contouring, their clinical applicability to real‐world cases containing anatomical variations and artifacts requires rigorous validation.
Ryota Tozuka, Masahide Saito, Masaki Matsuda, Tomoko Akita, Hikaru Nemoto, Zhe Chen, Takafumi Komiyama, Kazuma Mochizuki, Noriyuki Kadoya, Keiichi Jingu, Hiroshi Onishi   +10 more
wiley   +1 more source

Author Correction: Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions. [PDF]

Nat Commun
Liu J, Dai L, Wang Q, Li C, Liu Z, Gong T, Xu H, Jia Z, Sun W, Wang X, Lu M, Shang T, Zhao N, Cai J, Li Z, Chen H, Su J, Liu Z.   +17 more
europepmc   +1 more source

Scleroderma‐Specific Autoantibodies and Disease Trajectories in Early Systemic Sclerosis: Insights From a Single‐Center Prospective Registry

ACR Open Rheumatology, Volume 8, Issue 9, September 2026.
Objective Early diffuse cutaneous systemic sclerosis (dcSSc) is associated with substantial disease‐specific mortality. Scleroderma‐specific autoantibodies (SSc‐Ab) may influence disease course, but their prognostic value in very early dcSSc remains unclear.
Marzieh Jamali, Amisha Kaur, Suiyuan Huang, Carleigh Zahn, Erica Mulcaire‐Jones, John Varga, Dinesh Khanna   +6 more
wiley   +1 more source

Solanum nigrum-Derived Carbon Dots Alleviate Tumor Hypoxia to Potentiate Photodynamic Therapy in Esophageal Squamous Cell Carcinoma. [PDF]

Adv Healthc Mater
Luo SN, Zheng GS, Jin J, Wang XL, Li WY, Xu N, Yang WJ, Chen YS, Zhang JT, Lou Q, Zhang ZS, Zhang LG.   +11 more
europepmc   +1 more source

Clinical Phenotypes, Treatment, and Outcomes of Rheumatic Immune–Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors: A Rheumatologists‐Referred Multicenter German Registry Cohort

ACR Open Rheumatology, Volume 8, Issue 9, September 2026.
Objective Immune checkpoint inhibitors (ICIs) induce a broad range of immune‐related adverse events (irAEs), including rheumatic manifestations. Evidence from dedicated rheumatology cohorts on the clinical spectrum, severity, treatment, and outcomes of rheumatic irAEs (rh‐irAEs) remains limited.
Didzis Gailis, Fabian T.H. Ullrich, Sophia Dombret, Marc Schmalzing, Rebecca Hasseli‐Fräbel, Torsten Witte, Thea Thiele, Uta Kiltz, Mara Oleszowsky, Marcel Müller, Karolina Gente, Christof Specker, Matthias B. Thaler, Alla Skapenko, Hendrik Schulze‐Koops   +14 more
wiley   +1 more source